Health
Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine – benefits still outweigh risks – News-Medical.Net
New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory…
Pharmaceutical and biotechnology company AstraZeneca had recently come under fire for rare blood clotting events — causing a temporary suspension of the vaccine in multiple countries. In April, the European Medicines Agency concluded the vaccine is potentially linked to blood clotting in people with low blood platelets who received the dose. However, they emphasized unusual blood clotting was a rare side effect.
New research published in BMJ confirmed evidence of blood clotting finding a small risk…
-
General24 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
Noosa News23 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoDavid Littleproud’s own goal • Inside Story
-
Noosa News16 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations